Gaya APA

Prognostic value of tumor-infiltrating lymphocytes among HER-2+ breast cancer patients receiving trastuzumab-based adjuvant therapy. (2022). Jakarta: Indonesian Society of Oncology.

Gaya MLA

Prognostic value of tumor-infiltrating lymphocytes among HER-2+ breast cancer patients receiving trastuzumab-based adjuvant therapy. . Jakarta: Indonesian Society of Oncology, 2022. Artikel.